SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-072317
Filing Date
2022-11-14
Accepted
2022-11-14 16:43:31
Documents
95
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_abvcbio.htm   iXBRL 10-Q 1484462
2 CERTIFICATION f10q0922ex31-1_abvcbio.htm EX-31.1 8236
3 CERTIFICATION f10q0922ex31-2_abvcbio.htm EX-31.2 8189
4 CERTIFICATION f10q0922ex32-1_abvcbio.htm EX-32.1 4502
5 CERTIFICATION f10q0922ex32-2_abvcbio.htm EX-32.2 4021
  Complete submission text file 0001213900-22-072317.txt   8700860

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20220930.xsd EX-101.SCH 115973
7 XBRL CALCULATION FILE abvc-20220930_cal.xml EX-101.CAL 43151
8 XBRL DEFINITION FILE abvc-20220930_def.xml EX-101.DEF 406979
9 XBRL LABEL FILE abvc-20220930_lab.xml EX-101.LAB 829627
10 XBRL PRESENTATION FILE abvc-20220930_pre.xml EX-101.PRE 429450
89 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_abvcbio_htm.xml XML 1050244
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 221386786
SIC: 2834 Pharmaceutical Preparations